TickerFacts.

20/20 Biolabs, Inc. (AIDX): Total Liabilities

Annual figures by period end, from SEC filings.

$4.16M
As of 2025-12-31
$2.96M
As of 2026-06-30
2024-12-31: $2.08M2025-12-31: $4.16M$4.16M
2024-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$4.16M+99.9%2026-03-31, Balance as of period end
2024-12-31$2.08Mn/a2026-03-31, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
20/20 Biolabs, Inc. (AIDX)2025-12-31$4.16M+99.9%
NeoGenomics Inc (NEO)2025-12-31$523.27M-28.9%
UL Solutions Inc. (ULS)2025-12-31$1.63B-12.9%
Hypha Labs, Inc. (FUNI)2025-09-30$2.51M+76.9%

Compare AIDX, NEO, ULS, FUNI side by side · Screen every company in Services-Testing Laboratories ↗